BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24544513)

  • 1. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA; RANDALL E; THUM L; BARKER LF
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract]   [Full Text] [Related]  

  • 2. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY; NUSSER W; EPSTEIN S; VAN MAREN H; OZOG S
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic mixtures; in vitro effect of a tetracycline-oleandomycin mixture (PA 775) on staphylococci.
    Levitt RO; Hubble RH
    N Engl J Med; 1957 Jul; 257(4):180-1. PubMed ID: 13452068
    [No Abstract]   [Full Text] [Related]  

  • 5. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
    NOYES HE; NAGLE SC; SANFORD JP; ROBBINS ML
    Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory studies of oleandomycin (matromycin).
    GERACI JE; NEEDHAM GM
    Antibiotic Med Clin Ther (New York); 1956 Oct; 3(5):334-5. PubMed ID: 13363377
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ; HALL WH
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L; VACCARO H; VALENZUELA E
    Antibiot Annu; 1955-1956; 3():623-33. PubMed ID: 13355339
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF
    Antibiot Chemother (Northfield); 1958 Feb; 8(2):84-5. PubMed ID: 24544672
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of fixed combinations of antibiotics on Staphylococci in vitro.
    FURESZ S; ZANGAGLIA O; SCOTTI R
    Antibiot Chemother (Northfield); 1958 Nov; 8(11):571-5. PubMed ID: 24544980
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of antibiotic combinations on pathogenic staphylococci in vitro.
    MANTEN A
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):480-6. PubMed ID: 24544085
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
    GRIFFITH LJ; OSTRANDER WE
    Antibiot Chemother (Northfield); 1959 Jul; 9(7):416-8. PubMed ID: 24545275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-staphylococcal activity of novobiocin].
    Chabbert Y; Berrod J; Henoch H; Dumas J
    Presse Med (1893); 1958 May; 66(36):809 passim. PubMed ID: 13567446
    [No Abstract]   [Full Text] [Related]  

  • 14. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A
    Antibiot Chemother (Northfield); 1957 Jun; 7(6):297-305. PubMed ID: 24544434
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin.
    FAIRBROTHER RW; SOUTHALL JE
    Lancet; 1957 Nov; 273(7003):974-6. PubMed ID: 13482262
    [No Abstract]   [Full Text] [Related]  

  • 16. The participation of novobiocin and vancomycin in combined antibiotic action against staphylococci.
    BERTIE W; JAWETZ E; SONNE M
    Antibiotic Med Clin Ther (New York); 1957 Jan; 4(1):40-4. PubMed ID: 13382115
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 18. NEW ANTIBIOTICS in the fight against resistant staphylococci.
    Am J Pharm Sci Support Public Health; 1956 Sep; 128(9):300-4. PubMed ID: 13372757
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the incidence and distribution of antibiotic-resistant Staphylococci.
    HINTON NA; ORR JH
    J Lab Clin Med; 1957 Apr; 49(4):566-72. PubMed ID: 13406392
    [No Abstract]   [Full Text] [Related]  

  • 20. Rate of development of resistance in Staphylococcus aureus to erythromycin in combination with oleandomycin, vancomycin, or dihydrostreptomycin.
    HALL WH
    J Lab Clin Med; 1960 Jul; 56():83-104. PubMed ID: 14399074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.